https://ferringgermany.devcorp.ferring.tech/ferring-statement-on-minirin-octostim-ddavp-stimate-desmopressin-nasal-spray/ 2022-07-15T08:51:25+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-new-collaboration-for-development-of-olamkicept/ 2022-07-15T08:51:26+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-presents-new-analyses-of-efficacy-safety-and-microbiome-composition-data-at-ddw-2022-for-rbx2660-its-investigational-microbiota-based-live-biotherapeutic/ 2022-07-15T08:51:26+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/34/2022/05/iStock_89822515_LARGE-1.jpg https://ferringgermany.devcorp.ferring.tech/panicked-and-overwhelmed-new-study-reveals-the-emotional-and-psychological-impact-of-infertility/ 2022-07-15T08:51:28+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-delivered-record-results-in-2021-and-is-on-course-for-future-ambitions/ 2022-07-15T08:51:28+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-leadership-appointments-to-drive-next-phase-of-growth/ 2022-07-15T08:51:29+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-statement-on-the-ukraine-crisis/ 2022-07-15T08:51:29+00:00 https://ferringgermany.devcorp.ferring.tech/gender-health-and-racial-inequalities-to-be-tackled-in-flagship-ferring-grant-programme/ 2022-07-15T08:51:31+00:00 https://ferringgermany.devcorp.ferring.tech/women-in-india-are-the-first-in-the-world-to-receive-new-heat-stable-carbetocin-formulation-to-prevent-excessive-bleeding-after-childbirth/ 2022-07-15T08:51:36+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-announces-changes-to-board-of-directors/ 2022-07-15T08:51:39+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-presents-new-data-at-eshre-2021-supporting-the-use-of-rekovelle-follitropin-delta-for-individualized-fertility-treatment/ 2022-07-15T08:51:40+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-rebiotix-present-positive-interim-phase-3-results-from-open-label-study-of-investigational-microbiota-based-live-biotherapeutic-rbx2660-at-digestive-disease-week-ddw/ 2022-07-15T08:51:41+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-rebiotix-present-landmark-phase-3-data-demonstrating-superior-efficacy-of-investigational-rbx2660-versus-placebo-to-reduce-recurrence-of-c-difficile-infection/ 2022-07-15T08:51:42+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-rebiotix-to-present-landmark-data-for-investigational-microbiota-based-live-biotherapeutic-rbx2660-at-digestive-disease-week-ddw-2021/ 2022-07-15T08:51:43+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-jan-lundberg-to-group-board/ 2022-07-15T08:51:46+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-rebiotix-and-mybiotics-collaborate-to-develop-live-microbiome-based-therapeutics-in-reproductive-medicine-and-maternal-health/ 2022-07-15T08:51:47+00:00 https://ferringgermany.devcorp.ferring.tech/simple-pharma-acquires-testavan-and-vitaros-two-established-mens-health-brands-from-ferring/ 2022-07-15T08:51:48+00:00 https://ferringgermany.devcorp.ferring.tech/blog-post-becky-kearns/ 2022-07-15T08:51:52+00:00 https://ferringgermany.devcorp.ferring.tech/blog-post-nicole-narracott/ 2022-07-15T08:51:53+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-mirjam-mol-arts-to-executive-committee/ 2022-07-15T08:51:58+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-successfully-launches-its-inaugural-swiss-franc-bond-offering-for-an-amount-of-chf-270-million/ 2022-07-15T08:51:58+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-igenomix-collaborate-to-advance-care-in-reproductive-medicine-and-maternal-health/ 2022-07-15T08:51:59+00:00 https://ferringgermany.devcorp.ferring.tech/swissmedic-approves-carbetocin-ferring-for-the-prevention-of-postpartum-haemorrhage-in-all-births/ 2022-07-15T08:52:00+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2020/05/Assets-150x150-1.png https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2020/11/Sans-titre-1-1.png https://ferringgermany.devcorp.ferring.tech/ferring-statement-on-the-covid-19-novel-coronavirus-disease-pandemic-and-reproductive-medicine/ 2022-07-15T08:52:00+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/34/2020/06/Linkedin-post-statement.jpg https://ferringgermany.devcorp.ferring.tech/rebiotix-and-ferring-announce-worlds-first-with-positive-preliminary-pivotal-phase-3-data-for-investigational-microbiome-based-therapy-rbx2660/ 2022-07-15T08:52:01+00:00 https://ferringgermany.devcorp.ferring.tech/rebiotix-a-ferring-company-completes-enrollment-for-first-ever-pivotal-phase-3-clinical-trial-of-microbiota-based-rbx2660/ 2022-07-15T08:52:06+00:00 https://ferringgermany.devcorp.ferring.tech/ferrings-propess-is-the-first-pharmacological-treatment-for-cervical-ripening-to-be-approved-in-japan-for-over-20-years/ 2022-07-15T08:52:07+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2019/09/Assets.png https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2020/11/Sans-titre-1-1.png https://ferringgermany.devcorp.ferring.tech/ferring-70-anniversary/ 2022-07-15T08:52:10+00:00 https://ferringgermany.devcorp.ferring.tech/fergene-appoints-david-meek-chief-executive-officer/ 2022-07-15T08:52:12+00:00 https://ferringgermany.devcorp.ferring.tech/fergene-announces-pivotal-phase-3-study-of-nadofaragene-firadenovec/ 2022-07-15T08:52:15+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-blackstone-life-sciences-invest-over-570-million-usd-in-novel-gene-therapy-for-bladder-cancer-patients/ 2022-07-15T08:52:16+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/34/2019/11/ferring-bladder-cancer-infographic.png https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2020/11/Sans-titre-1-1.png https://ferringgermany.devcorp.ferring.tech/heat-stable-carbetocin-has-been-added-to-the-who-essential-medicines-list-for-the-prevention-of-excessive-bleeding-after-childbirth/ 2022-07-15T08:52:18+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/34/2019/07/ferring-heat-barrier-infographic.png https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2020/11/Sans-titre-1-1.png https://ferringgermany.devcorp.ferring.tech/ferring-rebiotix-and-karolinska-institutet-extend-collaboration-to-research-next-generation-of-microbiome-treatments/ 2022-07-15T08:52:18+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-changes-to-executive-committee/ 2022-07-15T08:52:18+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-collaboration-with-digital-health-innovators-woom-aims-to-help-more-people-build-families-faster/ 2022-07-15T08:52:18+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-statement-on-subsidised-pricing-of-heat-stable-carbetocin-for-the-prevention-of-postpartum-haemorrhage-in-low-and-lower-middle-income-countries/ 2022-07-15T08:52:18+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2019/10/Sans-titre-1-1.png https://ferringgermany.devcorp.ferring.tech/launch-of-clenpiq-sodium-picosulfate-magnesium-oxide-and-anhydrous-citric-acid/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-evotec-ag-form-strategic-research-alliance-in-reproductive-medicine-and-womens-health/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-retirement-of-michel-pettigrew-president-of-the-executive-board-and-chief-operating-officer/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-celmatix-launch-ambitious-genomics-collaboration-to-advance-care-in-reproductive-medicine-and-womens-health/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/new-analysis-of-rekovelle-data-further-supports-use-of-amh-to-personalise-fertility-treatment/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-signs-global-agreement-to-commercialise-novel-gene-therapy-for-bladder-cancer-patients/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2020/11/Sans-titre-1-1.png https://ferringgermany.devcorp.ferring.tech/ferring-acquires-innovative-biotechnology-company-and-microbiome-pioneer-rebiotix-inc/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/nocturia-the-most-common-cause-of-a-poor-nights-sleep-say-experts-on-world-sleep-day/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-positive-outcome-of-european-decentralised-procedure-dcp-for-testavan-a-treatment-for-men-with-hypogonadism/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/march-of-dimes-and-ferring-announce-new-prematurity-research-center-at-imperial-college-london/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-msd-announce-completion-of-largest-clinical-trial-ever-conducted-in-postpartum-haemorrhage/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-30-million-chf-investment-in-new-biotech-centre-in-switzerland/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferrings-heat-stable-carbetocin-could-save-thousands-of-womens-lives-by-preventing-excessive-bleeding-after-childbirth/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-enters-into-worldwide-omniab-platform-license-agreement-with-ligand/ 2022-07-15T08:52:19+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-rekovelle-follitropin-delta/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-testavan-testosterone/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/acquisition-of-rebiotix-inc-microbiota-restoration-therapy/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/global-agreement-with-fkd-to-commercialise-novel-gene-therapy-for-bladder-cancer-patients/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-the-chinese-academy-of-sciences-collaborate-to-advance-research-in-reproductive-medicine/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/new-ferring-and-ache-laboratorios-farmaceuticos-facility-opens-to-optimise-drug-delivery-using-nanotechnology/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/fda-approves-ferrings-clenpiq-sodium-picosulfate-magnesium-oxide-and-anhydrous-citric-acid-oral-solution-for-colonoscopy-prep/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-receives-swiss-approval-for-rekovelle-the-first-personalised-fertility-treatment-using-an-approved-dosing-algorithm/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-strengthens-growth-hormone-franchise-zomacton-through-acquisition-of-zomajet-needle-free-injector-device/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-klaus-dugi-as-executive-vice-president-and-chief-medical-officer/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-new-analysis-of-rekovelle-data-relating-to-personalised-medicine-in-fertility-patients/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-lars-peter-brunse-to-executive-board/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-aaron-graff-to-executive-board/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/paul-navarre-joins-ferring-pharmaceuticals-as-chief-executive-officer-of-ferring-holding-inc/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-commits-10-million-to-march-of-dimes-to-expand-research-needed-to-end-preterm-birth/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-exclusive-agreement-with-alrise-biosystems-for-the-development-of-an-injectable-controlled-release-peptide/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-highlights-progress-on-social-and-environmental-goals-in-corporate-social-responsibility-csr-review-2015-2016/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/34/2017/04/csr-2015-16-front-cover-scaled-1.jpg https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2020/11/Sans-titre-1-1.png https://ferringgermany.devcorp.ferring.tech/ferring-appoints-dominic-moorhead-as-executive-vice-president-and-chief-financial-officer/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-cdi-sign-agreement-granting-ferring-exclusive-marketing-rights-to-vsl3-in-europe-and-canada/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/waking-up-to-go-to-the-toilet-is-the-number-one-cause-of-a-poor-nights-sleep-say-experts-on-world-sleep-day/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-collaborates-with-icf-on-development-of-a-potential-new-treatment-for-anal-fissures-with-a-focus-on-improving-quality-of-care-for-ibd-patients/ 2022-07-15T08:52:20+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-north-zealand-university-hospital-mark-first-milestone-in-innovative-ibd-collaboration/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-phase-3-data-for-investigational-human-recombinant-fsh-with-individualised-dosing-regimen-at-the-32nd-annual-meeting-of-eshre/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-acquires-exclusive-licensing-rights-to-condoliase-from-seikagaku-corporation/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-announces-approval-of-new-tailored-dosing-regimen-in-the-picoprep-sodium-picosulfate-magnesium-oxide-citric-acid-label-in-mrp-countries-in-europe/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-north-zealand-university-hospital-announce-ehealth-collaboration-aimed-at-transforming-ibd-patient-care/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-announces-approval-for-nocdurna-a-new-therapeutic-option-for-the-treatment-of-adults-waking-multiple-times-to-urinate-at-night/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/newly-created-swiss-polar-institute-to-launch-a-major-antarctic-expedition/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-nocdurna-desmopressin/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/wake-up-to-nocturia-the-most-common-cause-of-disrupted-sleep-that-could-be-damaging-your-health/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-acquires-ex-u-s-assets-and-rights-for-vitaros-alprostadil-cream-apricus-on-demand-topical-cream-for-erectile-dysfunction/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-receives-positive-chmp-opinion-for-rekovelle-follitropin-delta/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-foresee-pharmaceuticals-enter-into-exclusive-development-and-option-agreement/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-enteris-biopharma-enter-license-agreement-to-develop-an-oral-formulation-of-a-peptide-based-injectable-therapeutic/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-partners-with-intralytix-to-develop-bacteriophage-treatments-for-conditions-associated-with-the-microbiome-and-drug-resistant-bacteria/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-imab-sign-licensing-agreement-granting-imab-exclusive-rights-in-asia-to-olamkicept-for-the-treatment-of-autoimmune-disease/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-receives-eu-approval-for-rekovelle-follitropin-delta/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-collaborates-with-metabogen-ab-on-development-of-microbiome-based-treatment-for-intrahepatic-cholestasis-of-pregnancy-icp/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-ache-laboratorios-farmaceuticos-collaborate-on-nanotechnology-rd-platform/ 2022-07-15T08:52:21+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-receives-acceptance-of-marketing-authorisation/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-submits-variation-application-to-introduce-new-tailored-dosing-regimen-in-the-picoprep/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/targeted-immuno-therapies-ab-and-ferring-pharmaceuticals-sign-a-strategic-collaboration-agreement-for-the-treatment-of-ibd/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-acquires-global-rights-to-milprosa-progesterone-vaginal-ring/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-opens-asia-pacific-headquarters-in-singapore/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/healthcare-supply-chain-academy-hsca-program/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-karolinska-institutet-sign-collaboration-agreement/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-the-start-of-the-pronounce-trial/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/cosmo-ferring-pharmaceuticals-enter-into-licensing-agreement-for-cortimentmmx-budesonide-in-japan/ 2022-07-15T08:52:22+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-european-approval-of-new-room-temperature-stable-formulation-of-pabal-carbetocin/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-begins-phase-2b-3-trial-of-selepressin-for-treatment-of-septic-shock/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-moves-forward-with-early-stage-development-of-bacteriophage-therapy-for-inflammatory-bowel-disease/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/inflammatory-bowel-disease-treatment-gets-boost-from-new-educational-resource/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-the-institut-pasteur-collaborate-in-novel-ibd-drug-development-project/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-european-approval-of-new-room-temperature-stable-formulation-of-pabal-carbetocin/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-acquires-novel-drug-delivery-technology-from-ctcbio-inc/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-european-launch-of-cortimentmmx-budesonide-for-ulcerative-colitis-and-new-data-re-confirms-safety-and-efficacy/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-acquires-two-phase-iii-ready-orthobiologic-product-candidates-from-bioset/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-moves-to-strengthen-growth-with-appointment-of-chief-medical-and-chief-scientific-officers/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-announces-grand-opening-of-u-s-operations-center/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/wp-content/uploads/sites/16/2019/12/ferring-locations-parsippany-NJ-header.png https://ferringgermany.devcorp.ferring.tech/new-data-from-a-pooled-analysis-shows-improved-overall-survival-for-prostate-cancer/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/cortimentmmx-a-new-treatment-for-ulcerative-colitis-receives-european-approval/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/the-scottish-medicines-consortium-smc-accepts-mysodelle-for-use-in-nhs-scotland/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-roche-collaborate-to-develop-personalised-infertility-treatment/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-launches-guts4life-an-interactive-online-resource-for-people-with-inflammatory-bowel-disease/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/new-study-suggests-desmopressin-melt-improves-sleep-patterns-and-psychological-functioning-of-bedwetting-children/ 2022-07-15T08:52:23+00:00 https://ferringgermany.devcorp.ferring.tech/new-study-showed-desmopressin-melt-reduced-sleep-disruption-in-bedwetting-children/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-fda-acceptance-of-nda-filing-for-controlled-release-misoprostol-vaginal-insert-for-decreasing-time-to-vaginal-delivery-in-women/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferrings-european-marketing-authorisation-application-for-controlled-release-misoprostol-vaginal-delivery-system-for-the-induction-of-labour-accepted-for-review/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/fonds-de-solidarite-ftq-cti-life-sciences-fund-and-ferring-pharmaceuticals-create-a-new-biotech-in-quebec/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-cortiment-budesonide/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/fda-approves-ferrings-prepopik-sodium-picosulfate-magnesium-oxide-and-anhydrous-citric-acid-for-colonoscopy-prep/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/in-patients-with-active-left-sided-ulcerative-colitis-study-shows-once-daily-dose-of-mesalazine-granules-provided-similar-results-to-twice-daily-dose/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/real-world-patient-survey-data-shows-negative-impact-of-nocturia/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/msd-ferring-pharmaceuticals-and-the-world-health-organization-working-together-to-prevent-excessive-bleeding-in-women-after-childbirth/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/new-paper-indicates-a-potential-fifty-percent-reduction-in-cardiac-events-for-prostate-cancer-patients-with-pre-existing-cardiovascular-disease-when-treated-with-firmagon-degarelix-compared-to/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-appoints-alex-chang-senior-vice-president-asia-pacific/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/misodel-ferrings-removable-misoprostol-vaginal-delivery-system-approved-for-labour-induction-in-european-decentralised-procedure/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-second-3-million-donation-to-the-royal-textile-academy-of-bhutan/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-presents-phase-iii-data-for-a-controlled-release-misoprostol-vaginal-delivery-system-for-labour-induction-at-the-first-european-congress-on-intrapartum-care/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-begins-phase-iii-trials-of-elobixibat-new-compound-with-novel-mechanism-of-action-for-chronic-idiopathic-constipation/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-to-present-safety-analysis-for-firmagon-degarelix-at-the-american-urological-association-annual-meeting/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/data-suggest-lower-risk-of-cardiovascular-events-or-deaths-in-prostate-cancer-patients-treated-with-degarelix-compared-to-lhrh-agonists/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/new-data-highlight-considerable-burden-of-nocturia/ 2022-07-15T08:52:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-acquires-licensing-rights-for-elobixibat-from-albireo-ab/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-donates-10-million-to-the-salk-institute-for-biological-studies/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/new-data-show-that-firmagon-degarelix-is-non-inferior-to-the-combination-of-goserelin-plus-bicalutamide-at-reducing-prostate-volume-in-patients-with-advanced-hormone-dependent-prostate-cancer/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/similar-remission-results-shown-between-once-daily-4g-dose-and-twice-daily-2g-doses-of-mesalazine-pentasa-in-active-ulcerative-colitis/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-acquires-cytokine-pharmasciences-inc/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-new-million-euro-educational-initiative-with-international-federation-of-fertility-societies-iffs-and-elsevier/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/new-research-reveals-night-time-toilet-trips-are-not-a-trivial-problem/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/acquisition-of-cytokine/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/the-untold-impact-of-childhood-bedwetting-in-later-life/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/new-data-demonstrating-long-term-benefits-of-firmagon-degarelix-for-advanced-hormone-dependant-prostate-cancer-published-in-the-journal-of-urology/ 2022-07-15T08:52:25+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-celebrated-its-60th-anniversary/ 2022-07-15T08:52:26+00:00 https://ferringgermany.devcorp.ferring.tech/extension-study-with-firmagon-degarelix-showed-continued-benefits-for-prostate-cancer-patients-beyond-one-year/ 2022-07-15T08:52:26+00:00 https://ferringgermany.devcorp.ferring.tech/megaset-study-demonstrated-effectiveness-and-tolerability-of-menopur-after-icsi-in-gnrh-antagonist-cycles/ 2022-07-15T08:52:26+00:00 https://ferringgermany.devcorp.ferring.tech/smc-announces-acceptance-of-degarelix-firmagon-for-use-within-nhs-scotland/ 2022-07-15T08:52:26+00:00 https://ferringgermany.devcorp.ferring.tech/ongoing-extension-study-results-provide-further-evidence-for-first-line-use-of-firmagon-degarelix-in-advanced-prostate-cancer/ 2022-07-15T08:52:26+00:00 https://ferringgermany.devcorp.ferring.tech/xanodyne-and-ferring-announce-co-promote-for-zipsor/ 2022-07-15T08:52:27+00:00 https://ferringgermany.devcorp.ferring.tech/wake-up-to-nocturia-studies-reinforce-serious-associated-risk-of-nocturia/ 2022-07-15T08:52:27+00:00 https://ferringgermany.devcorp.ferring.tech/consider-the-whole-man-when-treating-prostate-cancer/ 2022-07-15T08:52:27+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-acquires-lysteda-from-xanodyne-pharmaceuticals-inc/ 2022-07-15T08:52:27+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-research-infertility-and-gynaecology-grant-frigga-2010-theme-announced/ 2022-07-15T08:52:28+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-donates-3-million-to-the-royal-textile-academy-of-bhutan/ 2022-07-15T08:52:28+00:00 https://ferringgermany.devcorp.ferring.tech/firmagon-has-a-significantly-greater-probability-of-psa-recurrence-free-survival-than-leuprolide-in-prostate-cancer-patients/ 2022-07-15T08:52:28+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-firmagon/ 2022-07-15T08:52:28+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-launches-new-international-fertility-media-award-fima-2010/ 2022-07-15T08:52:29+00:00 https://ferringgermany.devcorp.ferring.tech/new-data-supports-significant-economic-and-clinical-value-of-menopur-in-ivf/ 2022-07-15T08:52:29+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-announces-new-board-member/ 2022-07-15T08:52:29+00:00 https://ferringgermany.devcorp.ferring.tech/frost-sullivan-accolade-for-ferring-pharmaceuticals/ 2022-07-15T08:52:29+00:00 https://ferringgermany.devcorp.ferring.tech/firmagon-degarelix-is-launched-in-europe-for-the-treatment-of-advanced-prostate-cancer/ 2022-07-15T08:52:29+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-donates-1-million-to-mcgill-university/ 2022-07-15T08:52:30+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-fait-un-don-d1-million-a-luniversite-mcgill/ 2022-07-15T08:52:30+00:00 https://ferringgermany.devcorp.ferring.tech/european-commission-grants-ferring-pharmaceuticals-approval-of-firmagon-degarelix-for-treatment-of-prostate-cancer/ 2022-07-15T08:52:30+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-creates-executive-board/ 2022-07-15T08:52:30+00:00 https://ferringgermany.devcorp.ferring.tech/auxilium-pharmaceuticals-inc-announces-distribution-and-license-agreement-for-testim-in-europe-with-ferring-pharmaceuticals/ 2022-07-15T08:52:31+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-signs-distribution-agreement-with-biogaia-in-ireland-and-the-middle-east/ 2022-07-15T08:52:31+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-conaris-complete-license-agreement-for-new-recombinant-molecule-in-gastroenterology/ 2022-07-15T08:52:31+00:00 https://ferringgermany.devcorp.ferring.tech/committee-for-medicinal-products-for-human-use-chmp-recommends-granting-marketing-authorisation-for-firmagon-degarelix-for-treatment-of-prostate-cancer/ 2022-07-15T08:52:31+00:00 https://ferringgermany.devcorp.ferring.tech/fda-approves-ferring-pharmaceuticals-degarelix-generic-name-for-treatment-of-advanced-prostate-cancer/ 2022-07-15T08:52:31+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-completes-phase-3-study-of-degarelix-in-prostate-cancer-patients/ 2022-07-15T08:52:32+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-new-prestigious-infertility-and-gynaecology-research-grant-frigga-at-update-in-infertility-2008/ 2022-07-15T08:52:32+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-submits-new-drug-application-for-degarelix-a-prostate-cancer-treatment/ 2022-07-15T08:52:32+00:00 https://ferringgermany.devcorp.ferring.tech/positive-phase-3-data-unveiled-for-new-gnrh-blocker-degarelix/ 2022-07-15T08:52:32+00:00 https://ferringgermany.devcorp.ferring.tech/new-data-demonstrates-both-cost-and-efficacy-benefit-of-menopur-compared-to-recombinant-fsh-treatment/ 2022-07-15T08:52:33+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-announces-board-changes/ 2022-07-15T08:52:33+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-forges-worldwide-licensing-agreement-for-budesonide-mmx/ 2022-07-15T08:52:33+00:00 https://ferringgermany.devcorp.ferring.tech/superior-remission-rates-for-once-daily-use-of-pentasa-mesalazine-in-ulcerative-colitis/ 2022-07-15T08:52:33+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-headquarters-open/ 2022-07-15T08:52:34+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-officially-opens-its-production-site-and-global-administrative-headquarters/ 2022-07-15T08:52:34+00:00 https://ferringgermany.devcorp.ferring.tech/symposium-looks-at-potential-of-mesalazine-to-prevent-colorectal-cancer-in-ibd-14th-united-european-gastroenterology-week-21-25-october-2006/ 2022-07-15T08:52:34+00:00 https://ferringgermany.devcorp.ferring.tech/dongbao-to-acquire-ferrings-malmo-manufacturing-operation/ 2022-07-15T08:52:34+00:00 https://ferringgermany.devcorp.ferring.tech/inequality-in-treatment-access-remains-a-key-issue-for-infertile-couples-across-europe/ 2022-07-15T08:52:34+00:00 https://ferringgermany.devcorp.ferring.tech/leading-urology-experts-call-for-better-recognition-and-treatment-of-nocturia/ 2022-07-15T08:52:35+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-astellas-enter-a-license-agreement-on-degarelix-for-the-treatment-of-prostate-cancer-in-japan/ 2022-07-15T08:52:35+00:00 https://ferringgermany.devcorp.ferring.tech/degarelix-a-novel-gnrh-blocker-from-ferring-moves-into-phase-3/ 2022-07-15T08:52:35+00:00 https://ferringgermany.devcorp.ferring.tech/assisted-reproductive-technology-helps-address-demographic-challenge-in-europe/ 2022-07-15T08:52:35+00:00 https://ferringgermany.devcorp.ferring.tech/grand-opening-of-ferring-pharmaceuticals-china-co-ltd-zhongshan-manufacturing-site/ 2022-07-15T08:52:36+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-a-s-offentliggor-lukning-af-produktionsstedet-i-vanlose-ved-udgangen-af-2008/ 2022-07-15T08:52:36+00:00 https://ferringgermany.devcorp.ferring.tech/jens-peter-norgaard-awarded-prestigious-professorship-at-university-of-lund/ 2022-07-15T08:52:36+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-acquires-savient-pharmaceuticals-incs-global-biologics-manufacturing-business/ 2022-07-15T08:52:36+00:00 https://ferringgermany.devcorp.ferring.tech/mrs-eva-paulsen-ferring-co-founder-dies-at-86/ 2022-07-15T08:52:37+00:00 https://ferringgermany.devcorp.ferring.tech/new-ferring-com-goes-live/ 2022-07-15T08:52:37+00:00 https://ferringgermany.devcorp.ferring.tech/interview-with-ferrings-executive-chairman-marks-the-first-year-with-the-ferring-philosophy/ 2022-07-15T08:52:37+00:00 https://ferringgermany.devcorp.ferring.tech/prestigious-iciq-meeting-held-at-fic/ 2022-07-15T08:52:37+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-strengthens-its-infertility-portfolio-through-agreement-with-metris-therapeutics-for-vorozole/ 2022-07-15T08:52:37+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-kicks-off-campaign-for-newest-product-norprolac-at-the-international-eshre-conference-in-berlin/ 2022-07-15T08:52:38+00:00 https://ferringgermany.devcorp.ferring.tech/new-nocturia-section-launched-on-minirin-com/ 2022-07-15T08:52:38+00:00 https://ferringgermany.devcorp.ferring.tech/degarelix-a-new-gnrh-blocker-from-ferring/ 2022-07-15T08:52:38+00:00 https://ferringgermany.devcorp.ferring.tech/degarelix-a-new-gnrh-blocker-from-ferring/ 2022-07-15T08:52:38+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-building-receives-award/ 2022-07-15T08:52:39+00:00 https://ferringgermany.devcorp.ferring.tech/study-reveals-that-women-undergoing-a-cycle-of-ivf-treatment-with-menopur-may-have-a-significantly-improved-chance-of-becoming-pregnant/ 2022-07-15T08:52:39+00:00 https://ferringgermany.devcorp.ferring.tech/international-experts-recommend-that-children-who-want-to-be-treated-for-bedwetting-should-be-offered-desmopressin-or-alarm-therapy/ 2022-07-15T08:52:39+00:00 https://ferringgermany.devcorp.ferring.tech/experts-confirm-lh-activity-as-an-essential-component-in-infertility-treatment/ 2022-07-15T08:52:39+00:00 https://ferringgermany.devcorp.ferring.tech/additional-data-for-menopur-hp-hmg/ 2022-07-15T08:52:40+00:00 https://ferringgermany.devcorp.ferring.tech/updates-in-infertility-congress/ 2022-07-15T08:52:40+00:00 https://ferringgermany.devcorp.ferring.tech/research-by-2003-nobel-laureate-in-chemistry-fills-in-scientific-gaps-necessary-for-ferring-researchers-to-develop-incontinence-product-focusing-on-the-kidney/ 2022-07-15T08:52:40+00:00 https://ferringgermany.devcorp.ferring.tech/dr-eberhard-zinn-ferring-board-member-dies-at-66/ 2022-07-15T08:52:40+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-president-of-the-ferring-research-institute/ 2022-07-15T08:52:40+00:00 https://ferringgermany.devcorp.ferring.tech/starting-signal-for-ferrings-fifth-production-site/ 2022-07-15T08:52:41+00:00 https://ferringgermany.devcorp.ferring.tech/new-evidence-shows-incidence-of-colo-rectal-cancer-may-be-reduced-in-patients-with-ulcerative-colitis/ 2022-07-15T08:52:41+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-acquires-norprolac/ 2022-07-15T08:52:41+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-acquires-dupomar/ 2022-07-15T08:52:41+00:00 https://ferringgermany.devcorp.ferring.tech/counting-the-costs-of-nightly-visits-to-the-bathroom-businesses-lose-e-14-million-euros-each-year-in-reduced-productivity/ 2022-07-15T08:52:42+00:00 https://ferringgermany.devcorp.ferring.tech/the-incredible-egg/ 2022-07-15T08:52:42+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-to-build-state-of-the-art-production-site-in-saint-prex/ 2022-07-15T08:52:42+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-grants-dr-frederik-paulsen-memorial-award-in-japan/ 2022-07-15T08:52:42+00:00 https://ferringgermany.devcorp.ferring.tech/new-infertility-study-significant-difference-between-treatments/ 2022-07-15T08:52:42+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-international-center-opens-for-business/ 2022-07-15T08:52:43+00:00 https://ferringgermany.devcorp.ferring.tech/first-international-consultation-on-nocturia-sheds-light-on-neglected-disease-area/ 2022-07-15T08:52:43+00:00 https://ferringgermany.devcorp.ferring.tech/new-website-about-primary-nocturnal-enuresis-opened-in-scandinavia/ 2022-07-15T08:52:43+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-featured-in-the-american-medical-review-television-series/ 2022-07-15T08:52:43+00:00 https://ferringgermany.devcorp.ferring.tech/her-majesty-the-queen-of-sweden-addresses-salk-institute-meeting-on-childhood-diseases-in-stockholm/ 2022-07-15T08:52:43+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-new-board-member-2/ 2022-07-15T08:52:44+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-and-johnson-johnson-join-in-a-research-collaboration/ 2022-07-15T08:52:44+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-pharmaceuticals-and-beth-israel-deaconess-medical-center-announce-drug-discovery-collaboration-agreement/ 2022-07-15T08:52:44+00:00 https://ferringgermany.devcorp.ferring.tech/5-asas-mesalazine-may-lower-colorectal-cancer-risk-in-inflammatory-bowel-disease-ibd/ 2022-07-15T08:52:44+00:00 https://ferringgermany.devcorp.ferring.tech/building-for-the-21st-century/ 2022-07-15T08:52:45+00:00 https://ferringgermany.devcorp.ferring.tech/fda-approves-bravelle-urofollitropin-for-injection-purified/ 2022-07-15T08:52:45+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-new-board-member/ 2022-07-15T08:52:45+00:00 https://ferringgermany.devcorp.ferring.tech/taking-the-needle-out-of-the-injection/ 2022-07-15T08:52:45+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-appoints-new-vice-president-of-global-marketing/ 2022-07-15T08:52:45+00:00 https://ferringgermany.devcorp.ferring.tech/ferrings-founder-dies-at-88/ 2022-07-15T08:52:46+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-tractocile/ 2022-07-15T08:52:46+00:00 https://ferringgermany.devcorp.ferring.tech/new-ferring-international-center-opens-for-business/ 2022-07-15T08:52:46+00:00 https://ferringgermany.devcorp.ferring.tech/advances-in-infertility/ 2022-07-15T08:52:46+00:00 https://ferringgermany.devcorp.ferring.tech/new-activities-in-prague/ 2022-07-15T08:52:47+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-menogon/ 2022-07-15T08:52:47+00:00 https://ferringgermany.devcorp.ferring.tech/winter-school/ 2022-07-15T08:52:47+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-zomacton/ 2022-07-15T08:52:47+00:00 https://ferringgermany.devcorp.ferring.tech/kiel-ferring-foundation/ 2022-07-15T08:52:48+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-minirin-tablet/ 2022-07-15T08:52:48+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-pentasa/ 2022-07-15T08:52:48+00:00 https://ferringgermany.devcorp.ferring.tech/frederik-paulsen-junior-becomes-chairman/ 2022-07-15T08:52:48+00:00 https://ferringgermany.devcorp.ferring.tech/new-worldwide-subsidiaries/ 2022-07-15T08:52:48+00:00 https://ferringgermany.devcorp.ferring.tech/new-production-site/ 2022-07-15T08:52:49+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-glypressin/ 2022-07-15T08:52:49+00:00 https://ferringgermany.devcorp.ferring.tech/continuous-expansion/ 2022-07-15T08:52:49+00:00 https://ferringgermany.devcorp.ferring.tech/launch-of-minirin-2/ 2022-07-15T08:52:49+00:00 https://ferringgermany.devcorp.ferring.tech/1950-laying-the-foundation-for-ferring/ 2022-07-15T08:52:50+00:00 https://ferringgermany.devcorp.ferring.tech/laying-the-foundation-for-ferring/ 2022-07-15T08:52:50+00:00 https://ferringgermany.devcorp.ferring.tech/strong-roots-decide-name/ 2022-07-15T08:52:50+00:00 https://ferringgermany.devcorp.ferring.tech/expansion/ 2022-07-15T08:52:50+00:00 https://ferringgermany.devcorp.ferring.tech/expansion-2/ 2022-07-15T08:52:50+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announce-ground-breaking-and-inclusive-family-building-benefits-package-for-all-its-employees-globally/ 2022-08-24T05:09:54+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-recipients-of-2018-19-innovation-grants/ 2023-03-31T06:24:33+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-recipients-of-innovation-grants-program-2017-2018/ 2023-03-31T06:26:24+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-announces-recipients-of-innovation-grants-program-2016-2017/ 2023-03-31T06:29:35+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-demonstrates-commitment-to-rd-investment-through-expanded-innovation-grants-program/ 2023-03-31T06:30:33+00:00 https://ferringgermany.devcorp.ferring.tech/ferring-named-in-fortunes-2023-change-the-world-list/ 2023-11-22T10:10:33+00:00 https://ferringgermany.devcorp.ferring.tech/new-data-show-durable-response-following-treatment-with-adstiladrin-nadofaragene-firadenovec-vncg/ 2024-07-17T10:25:33+00:00